HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 9 October 2017

Latest Publications from HEDS in September

Our regular monthly trawl for new publications from HEDS in collaboration with colleagues in ScHARR and further afield never fails to discover fresh research. Many of these are currently in press and you can find much of our work in its open access form via our institutional repository. Tuck in here. 

Image of Journal of Health Economics cover
© Elsevier                              
Brazier J, Rowen DL, Karimi M, Peasgood T, Tsuchiya A, Ratcliffe J. Experience-based utility and own health state valuation for a health state classification system: why do it and how to do it. European Journal of Health Economics

Chambers D, Preston L, Topakas A, de Saille S, Salway S, Booth A, Dawson J, Wilsdon J. Review of diversity and inclusion literature and an evaluation of methodologies and  metrics relating to health research. Available at: https://wellcome.ac.uk/sites/default/files/review-of-diversity-and-inclusion-literature.pdf

Poku EN, Aber A, Phillips P, Essat M, Woods H, Palfreyman S, Kaltenthaler E, Jones G, Michaels J. Systematic review assessing the measurement properties of patient-reported outcomes for venous leg ulcers. British Journal of Surgery

Image of Journal of Epidemiology and Community Health Journal
© BMJ Journals
Sadler S, Tosh J, Pennington R, Rawdin A, Squires H, Romero C, Fischer A, Chilcott J. A cost-effectiveness analysis of condom distribution programmes for the prevention of sexually transmitted infections in England. Journal of Epidemiology and Community Health (2017) 71:897–904. doi:10.1136/jech-2017-209020

Chambers D, Preston L, Salway S, De Saille S, Topakas A, Booth A, Dawson J, Wilsdon JR. The Diversity Dividend: does a more diverse and inclusive research community produce better biomedical and health research? Sheffield: TUOS/Wellcome Trust (2017). Available at: https://wellcome.ac.uk/sites/default/files/the-diversity-dividend-briefing.pdf

Dixon S. Determining the relative cost effectiveness of the fluocinolone acetonide intravitreal implant. Current Medical Research and Opinion (2017) 33:1–2. doi:10.1080/03007995.2017.1366624

Image of PharmacoEconomics Journal
© Adis
Brazier JE, Muston D, Konwea H, Power GS, Barzey V, Lloyd A, Sowade O, Vitti B, Gerlinger C, Roberts. Evaluating the Relationship Between Visual Acuity and Utilities in Patients With Diabetic Macular Edema Enrolled in Intravitreal Aflibercept Studies. Investigative Ophthalmology & Visual Science (2017) 58:4818–4825. doi:10.1167/iovs.17-21945

Bermejo I, Stevenson M, Cooper K, Harnan S, Hamilton J, Clowes M, Carroll C, Harrison T, Saha S. Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics (2017) doi:10.1007/s40273-017-0571-8

Bermejo I, Tappenden P, Youn J-H. Response to “Comment on ‘Replicating Health Economic Models: Firm Foundations or a House of Cards?’”. Pharmacoeconomics (2017) doi:10.1007/s40273-017-0574-5